2026-01-09 · 个股论点

AXTI因InP衬底垄断地位及全产业链优势受益，股价上涨逻辑多维。

中文翻译

$AXTI 从 Northland 获得 1 亿美元用于资本支出扩张，推迟的自由现金流（FCF）源自 2024 年或 2025 年初的 500 万美元合同收入，这并无实质性影响。股价上涨是多方面的： -> 认识到磷化铟(InP)衬底将成为光子学领域 AI 行业部署的瓶颈 -> 认识到 InP 衬底生产是双寡头垄断（住友、$AXTI），还有 JX 等较小玩家 -> 认识到 InP 原料是 InP 衬底生产商（$AXTI、Vital）的另一个瓶颈，还有 $DOWA 等较小玩家 -> 来自 $COHR 等财报的供应短缺通知 -> 认识到西方超大规模云服务商在 12 月 24 日左右在伦敦金属交易所(SMM)价格之上支付溢价 -> 认识到两天前中国对日本实施出口管制后，AXT 实际上成为垄断者（这将限制其主要竞争对手的大规模衬底生产）。估计有 3-6 个月的库存。 7N 级产品价格已达历史新高，$AXTI 拥有从矿山到衬底生产的全产业链，因此西方超大规模云服务商与 SMM 之间的多次涨价和溢价分化将增加其底线利润。我个人认为，在整个供应瓶颈出现之前，合同积压订单和推迟一个季度的合同收入（追溯至 2024 年或 2025 年初）并不构成实质性影响。但解读因人而异。

英文原文

$AXTI secured $100m from Northland for capex expansion, deferred FCF from $5m of contracted revenue from 2024 or early 2025 does not make a material difference. Stock runup was multifaceted: -> Recognition that InP substrates would bottleneck the AI industry deployment with photonics -> Recognition that InP substrate production was a duopoly (Sumitomo, $AXTI), with some smaller players like JX ->Recognition that InP feedstock was another bottleneck for the InP substrate producers ( $AXTI, Vital) with some smaller players like $DOWA. -> Supply shortage notice from earnings reports like $COHR -> Recognition that Western hypescalers are paying markups on top of SMM prices ~Dec 24th -> Recognition that AXT effectively became a monopoly after China's export controls on Japan 2 days ago (which would limit substrate production at scale from AXT's major competitor). Est 3-6 months inventory. 7n prices have hit ATHs, $AXTI owns the mines all the way to substrate production so many price increases and bifurcation in premiums between western hyperscalers + SMM would increase their bottom line. I personally don't consider contracted backlog and 1 quarter deferred contracted revenue all the way back from 2024 or early 2025 to be material before the entire supply chokepoint started. But to each their own interpretation.

在 X 上查看原推 ↗